Evidence map›Paper›PMID 32316949›Full record

ArticleBMC musculoskeletal disorders2020

Normal trajectory of Interleukin-6 and C-reactive protein in the perioperative period of total knee arthroplasty under an enhanced recovery after surgery scenario.

Ze Yu Huang, Qiang Huang, Li Ying Wang, Yi Ting Lei, Hong Xu, Bin Shen, Fu Xing Pei

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06936709 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Colchicine in the Perioperative Period on Reducing Post-Operative Pain in Total Knee Arthroplasty

TypeinterventionalSponsorGeisinger ClinicRan2025 to 2026Enrolled75ConditionsOsteoarthritis of Knee, Recovery Following Primary Total Knee Arthroplasty, Perioperative Pain ControlArmsColchicine 1.8 mg (loading dose) + Dextrose Oral Placebo, Colchicine 1.8 mg + 0.6 mg, Dextrose Oral Placebo
NCT07231926 narecruitingnot on this mapstarted 2025, after this paper: background citation

The Effects of Intrathecal Morphine in Addition to Serratus Anterior Plane Block and Dexmedetomidine on Postoperative Recovery (QoR-15) and Systemic Inflammation in Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial

TypeinterventionalSponsorAtaturk UniversityRan2025 to 2026Enrolled52ConditionsPostoperative Pain Management in Video-Assisted Thoracoscopic SurgeryArmsIntrathecal Morphine, Serratus Anterior Plane Block (SAPB) group, Dexmedetomidine
NCT07688642 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Boosting Venous Return After Knee Replacement: Effects of a Novel Circulatory Exercise on Early Postoperative Inflammation - A Randomized Controlled Trial

TypeinterventionalSponsorAssiut UniversityRan2026 to 2027Enrolled68ConditionsTotal Knee Replacement, Knee Osteoarthritis, Postoperative Edema, Postoperative InflammationArmsstandard postoperative TKR rehabilitation, Standard Rehabilitation Plus Circulatory Exercise
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. 28-day sepsis mortality prediction model from combined serial interleukin-6, lactate, and procalcitonin measurements: a retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  16. Observational
  17. Article
  18. Metallic Implants Used in Lumbar Interbody Fusion.Materials (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ze Yu HuangDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China.
Qiang HuangDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China.
Li Ying WangDepartment of Operation Room, West China Hospital, West China Medical School, SiChuan University, ChengDu, SiChuan Province, People's Republic of China.
Yi Ting LeiDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China.
Hong XuDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China.
Bin ShenDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China. 492385233@qq.com.
Fu Xing PeiDepartment of Orthopedic Surgery, West China Hospital, West China Medical School, SiChuan University, 37# Wainan GuoXue Road, ChengDu, SiChuan Province, People's Republic of China. peifuxing1951@163.com.
Sichuan University · CN

Funding

China Health Ministry Program 201302007
6 · The paper itself

Abstract

backgroundWe designed the current study to understand the normal trajectories of interleukin-6 (IL-6) and C-reactive protein (CRP) in the immediate hours and days after primary total knee arthroplasty (TKA) under the management of an enhanced recovery after surgery (ERAS) protocol and examined whether one or the other returned to normal more quickly.

methodsIn this prospective cross-sectional study, we examined the plasma IL-6 and CRP levels in 100 patients undergoing primary TKA at the following time points: 12 h preoperatively as well as postoperatively 12 h, 48 h, 3 days and 2 weeks. Patients were followed up for 1 year to monitor the postoperative complications, especially the infection.

resultsIL-6 peaked at 48 h postoperatively. Then IL-6 started to decline at 3 days postoperatively and went back to baseline level at 2 weeks (p = 0.950). CRP peaked at 3 days postoperatively. At 2 weeks, CRP declined to a normal range, without being significantly different from the baseline level (p = 0.816).

conclusionWe found that under the ERAS scenario, the postoperative peak of IL-6 and CRP was deferred compared with previous studies. Compared to IL-6, CRP showed a gradual rise after surgery. Both of these two biomarkers returned to normal under the ERAS scenario. Future multiple-center studies with larger sample size can help define the thresholds of IL-6 and CRP for periprosthetic joint infection (PJI) early diagnosis. With these reference data, a clinician can make a quicker decision to perform aspiration to diagnose early PJI and benefits more patients.

Indexed as

Arthroplasty, Replacement, KneeAgedAged, 80 and overBiomarkersC-Reactive ProteinCross-Sectional StudiesFemaleHumansInflammation MediatorsInterleukin-6MaleMiddle AgedOsteoarthritis, KneePerioperative PeriodProspective StudiesBiomarkersC-Reactive ProteinInflammation MediatorsInterleukin-6CRPEnhanced recovery after surgeryERASIL-6Total knee arthroplasty

Identifiers

PMID32316949
PMCPMC7175526
OpenAlexW3016299987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.